CR8202A - Derivados sustituidos de dioxido de tiazol-beozoisotiazol, metodo para su produccion y uso de los mismos - Google Patents

Derivados sustituidos de dioxido de tiazol-beozoisotiazol, metodo para su produccion y uso de los mismos

Info

Publication number
CR8202A
CR8202A CR8202A CR8202A CR8202A CR 8202 A CR8202 A CR 8202A CR 8202 A CR8202 A CR 8202A CR 8202 A CR8202 A CR 8202A CR 8202 A CR8202 A CR 8202A
Authority
CR
Costa Rica
Prior art keywords
beozoisotiazol
tiazol
dioxide
production
same
Prior art date
Application number
CR8202A
Other languages
English (en)
Spanish (es)
Inventor
Petry Stefan
Baringhaus Karl-Heinz
Tennagels Norbert
Mueller Guenter
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of CR8202A publication Critical patent/CR8202A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CR8202A 2003-07-28 2006-01-18 Derivados sustituidos de dioxido de tiazol-beozoisotiazol, metodo para su produccion y uso de los mismos CR8202A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10334309A DE10334309A1 (de) 2003-07-28 2003-07-28 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung

Publications (1)

Publication Number Publication Date
CR8202A true CR8202A (es) 2008-10-15

Family

ID=34111694

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8202A CR8202A (es) 2003-07-28 2006-01-18 Derivados sustituidos de dioxido de tiazol-beozoisotiazol, metodo para su produccion y uso de los mismos

Country Status (37)

Country Link
EP (1) EP1651644B1 (enExample)
JP (1) JP2007500145A (enExample)
KR (1) KR20060052886A (enExample)
CN (1) CN100413862C (enExample)
AR (1) AR045113A1 (enExample)
AT (1) ATE346065T1 (enExample)
AU (1) AU2004261370B2 (enExample)
BR (1) BRPI0412997A (enExample)
CA (1) CA2533673A1 (enExample)
CR (1) CR8202A (enExample)
CY (1) CY1105962T1 (enExample)
DE (2) DE10334309A1 (enExample)
DK (1) DK1651644T3 (enExample)
EC (1) ECSP066326A (enExample)
ES (1) ES2276319T3 (enExample)
GT (1) GT200400146A (enExample)
IL (1) IL173289A0 (enExample)
JO (1) JO2449B1 (enExample)
MA (1) MA27932A1 (enExample)
MY (1) MY141197A (enExample)
NO (1) NO20060908L (enExample)
NZ (1) NZ544975A (enExample)
OA (1) OA13198A (enExample)
PA (1) PA8607201A1 (enExample)
PE (1) PE20050326A1 (enExample)
PL (1) PL1651644T3 (enExample)
PT (1) PT1651644E (enExample)
RS (1) RS20060015A (enExample)
RU (1) RU2350613C2 (enExample)
SA (1) SA04250332B1 (enExample)
SI (1) SI1651644T1 (enExample)
TN (1) TNSN06030A1 (enExample)
TW (1) TW200524923A (enExample)
UA (1) UA83057C2 (enExample)
UY (1) UY28443A1 (enExample)
WO (1) WO2005012295A1 (enExample)
ZA (1) ZA200510378B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026532A1 (de) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CN101415683B (zh) 2006-03-31 2013-07-17 诺瓦提斯公司 新化合物
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
JP2013503135A (ja) 2009-08-26 2013-01-31 サノフイ 新規な結晶性複素芳香族フルオログリコシド水和物、その化合物を含んでなる医薬及びその使用
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2012120058A1 (de) 2011-03-08 2012-09-13 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683703B1 (de) 2011-03-08 2015-05-27 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683698B1 (de) 2011-03-08 2017-10-04 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2025017207A1 (en) * 2023-07-20 2025-01-23 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Inhibitors of smndc1 and their therapeutic use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
RU2164226C2 (ru) * 1995-06-02 2001-03-20 Санофи-Синтелябо Производные 5-(гидроксиметил)-оксазолидин-2-она, способы их получения, лекарство и фармацевтический состав
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
AU2004261370A1 (en) 2005-02-10
PL1651644T3 (pl) 2007-03-30
DK1651644T3 (da) 2007-03-26
HK1091825A1 (en) 2007-01-26
RS20060015A (sr) 2007-12-31
PT1651644E (pt) 2007-01-31
EP1651644B1 (de) 2006-11-22
MA27932A1 (fr) 2006-06-01
UA83057C2 (ru) 2008-06-10
IL173289A0 (en) 2006-06-11
SA04250332B1 (ar) 2008-02-25
ATE346065T1 (de) 2006-12-15
DE10334309A1 (de) 2005-03-03
TW200524923A (en) 2005-08-01
NZ544975A (en) 2010-02-26
SI1651644T1 (sl) 2007-02-28
DE502004002117D1 (de) 2007-01-04
CN1829715A (zh) 2006-09-06
WO2005012295A1 (de) 2005-02-10
BRPI0412997A (pt) 2006-10-03
ZA200510378B (en) 2006-11-29
CA2533673A1 (en) 2005-02-10
NO20060908L (no) 2006-02-24
OA13198A (en) 2006-12-13
PE20050326A1 (es) 2005-06-16
AR045113A1 (es) 2005-10-19
CY1105962T1 (el) 2011-04-06
JP2007500145A (ja) 2007-01-11
JO2449B1 (en) 2008-10-09
CN100413862C (zh) 2008-08-27
RU2350613C2 (ru) 2009-03-27
TNSN06030A1 (en) 2007-10-03
UY28443A1 (es) 2005-02-28
EP1651644A1 (de) 2006-05-03
PA8607201A1 (es) 2005-03-03
KR20060052886A (ko) 2006-05-19
ECSP066326A (es) 2006-07-28
ES2276319T3 (es) 2007-06-16
MY141197A (en) 2010-03-31
AU2004261370B2 (en) 2009-07-16
GT200400146A (es) 2005-08-12
RU2006106231A (ru) 2006-06-27

Similar Documents

Publication Publication Date Title
CR8202A (es) Derivados sustituidos de dioxido de tiazol-beozoisotiazol, metodo para su produccion y uso de los mismos
IL172899A0 (en) Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
ATE481402T1 (de) Pyrazolopyridin-derivate
CR10709A (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
CY2200154T2 (el) Κινητες εργοστασιακες μοναδες και συστηματα, μεθοδοι για την παραγωγη αφαλατωμενου υδατος
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
NO20054224D0 (no) Nye 2-pyridinkarboksamidderivater
IS8146A (is) Setnar 3-alkýl og 3-alkenýl asetidín afleiður
NO20054905D0 (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
NO20053356D0 (no) Aminindazolderivater og anvendelse derav som kinaseinhibitorer.
CR8226A (es) Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos
ATE420066T1 (de) Amidoacetonitrilderivate
ATE352550T1 (de) Chinazolinderivate
IS2733B (is) Afleiður af díoxan-2-alkýlkarbamötum, framleiðsluaðferð þeirra, milliefni notuð við framleiðsluna, og notkun þeirra í meðferð.
ATE348609T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE395345T1 (de) Imidazol-4-yl-ethynyl-pyridin-derivate
ATE512148T1 (de) Pyrazolo- und imidazopyrimidinderivate
IS2656B (is) Nýjar besímídasólafleiður
DE602004021572D1 (de) SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
ATE449064T1 (de) Amidoacetonitrilderivate
ATE542806T1 (de) Diarylmethylpiperazinderivate, deren herstellung und deren verwendung
DE602004006815D1 (de) Monolithischer Halbleiterlaser und dessen Herstellungsverfahren
DE602004005527D1 (de) Oberflächenemittierender Halbleiterlaser und dessen Herstellungsverfahren

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)